<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04788537</url>
  </required_header>
  <id_info>
    <org_study_id>820694</org_study_id>
    <nct_id>NCT04788537</nct_id>
  </id_info>
  <brief_title>Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders</brief_title>
  <official_title>Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test a novel, three-part cognitive behavioral treatment&#xD;
      strategy to improve social functioning in adults with autism spectrum disorder.&#xD;
&#xD;
      The treatment, named TUNE In (Training to Understand and Navigate Emotions and Interactions),&#xD;
      includes components to address the many behavioral domains involved in social functioning,&#xD;
      including social motivation, social anxiety, social cognition, social skills, and&#xD;
      generalization of the skills to community settings.&#xD;
&#xD;
      We will test the efficacy of TUNE In to improve social functioning in adults with autism&#xD;
      spectrum disorder (ASD), using a randomized controlled trial using the SRS-2 as the primary&#xD;
      outcome measure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 16, 2021</start_date>
  <completion_date type="Anticipated">December 22, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 22, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants randomly assigned to either the intervention group (50%) or nonintervention group (50%).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>reduction in Social Responsiveness Scale, Second Edition (SRS-2) - Adult (relative/other report)</measure>
    <time_frame>1 year</time_frame>
    <description>Scale ranges from 30 to 90 with higher T-scores indicating greater severity of autism symptomatology.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Autism</condition>
  <condition>Autism Spectrum Disorder</condition>
  <condition>Autistic Disorder</condition>
  <condition>Asperger Syndrome</condition>
  <condition>Pervasive Developmental Disorder</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Nonintervention Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Training to Understand and Navigate Emotions and Interactions (TUNE In)</intervention_name>
    <description>A three-part cognitive behavioral treatment strategy to improve social functioning in adults with autism spectrum disorder. TUNE In includes components to address the many behavioral domains involved in social functioning, including social motivation, social anxiety, social cognition, social skills, and generalization of the skills to community settings.</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosis of autism spectrum disorder&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  intellectual disability&#xD;
&#xD;
          -  severe mood or psychotic symptoms experienced in the past 4 weeks&#xD;
&#xD;
          -  severe self-injurious or aggressive behavior&#xD;
&#xD;
          -  severe extrapyramidal motor or sedating side effects of medications&#xD;
&#xD;
          -  concomitant participation in another social skills treatment program.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>James A Rankin, PhD</last_name>
    <phone>215-240-3092</phone>
    <email>james.rankin@pennmedicine.upenn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Perelman School of Medicine</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James A Rankin, PhD</last_name>
      <phone>215-240-3092</phone>
      <email>james.rankin@pennmedicine.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Edward Brodkin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 2, 2021</study_first_submitted>
  <study_first_submitted_qc>March 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2021</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Autism</keyword>
  <keyword>Autism Spectrum Disorder</keyword>
  <keyword>Cognitive Behavioral Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
    <mesh_term>Developmental Disabilities</mesh_term>
    <mesh_term>Asperger Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be available through NIH NDAR registry</ipd_description>
    <ipd_time_frame>Deidentified data will be uploaded to NDAR upon completion of the trial</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

